Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study

by Park, Keunchil, Janne, Pasi A., Kim, Dong-Wan, Han, Ji-Youn, Wu, Ming-Fang, Lee, Jong-Seok, Kang, Jin-Hyoung, Lee, Dae Ho, Cho, Byoung Chul, Yu, Chong-Jen, Pang, Yong Kek, Felip, Enriqueta, Kim, Hyunjin, Baek, Eunhye, Noh, Young Su
Published 2021